Cyteir Therapeutics (Series B)
Funding Details
- Awarder
- Inbox
- Date Award
- March 08, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $29,000,000
Company Info
- Founders
- Kevin Mills, Ph.D.
- Company Description
- Cyteir is developing the next generation of synthetic lethal therapies to treat cancer.
- Market
- Cancer and autoimmune diseases
- Location
- Cambridge, MA, USA
- Coinvestors
- Celgene Corporation, DROIA Oncology Ventures, Lightstone Ventures, Venrock